CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-17 | Taylor Stacy L SVP and General Counsel | Option exercise · Stock Option (Right to Buy) | −1,771 | 17,709 | ||
| 2021-06-17 | Taylor Stacy L SVP and General Counsel | Option exercise · Stock Option (Right to Buy) | −1,354 | 44,688 | ||
| 2021-06-17 | ADAMS R MARK Chief Operating Officer | Option exercise | +14,583 | $28.10 | $410K | 72,687 |
| 2021-06-17 | ADAMS R MARK Chief Operating Officer | Sale | −14,583 | $40.00 | $583K | 58,104 |
| 2021-06-17 | ADAMS R MARK Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −14,583 | 35,417 | ||
| 2021-06-17 | GRIFFIN MICHELLE RENEE Director | Option exercise | +4,000 | $7.80 | $31K | 5,504 |
| 2021-06-17 | GRIFFIN MICHELLE RENEE Director | Sale | −4,000 | $40.00 | $160K | 1,504 |
| 2021-06-17 | GRIFFIN MICHELLE RENEE Director | Option exercise · Stock Option (Right to Buy) | −4,000 | 69,500 | ||
| 2021-06-17 | Palaniappan Jyoti SVP, Diagnostics, T-Detect | Option exercise | +651 | $22.55 | $15K | 9,809 |
| 2021-06-17 | Palaniappan Jyoti SVP, Diagnostics, T-Detect | Sale | −651 | $40.00 | $26K | 9,158 |
| 2021-06-17 | Palaniappan Jyoti SVP, Diagnostics, T-Detect | Option exercise · Stock Option (Right to Buy) | −651 | 106,345 | ||
| 2021-06-17 | ROBINS CHAD M CEO and Chairman | Sale | −1,000 | $38.55 | $39K | 1,722,716 |
| 2021-06-17 | ROBINS CHAD M CEO and Chairman | Sale | −4,255 | $39.76 | $169K | 1,718,461 |
| 2021-06-16 | ROBINS CHAD M CEO and Chairman | Sale | −4,745 | $38.13 | $181K | 1,723,716 |
| 2021-06-15 | ROBINS CHAD M CEO and Chairman | Sale | −19,100 | $38.22 | $730K | 1,729,361 |
| 2021-06-15 | ROBINS CHAD M CEO and Chairman | Sale | −900 | $39.23 | $35K | 1,728,461 |
| 2021-06-14 | GRIFFIN MICHELLE RENEE Director | Option exercise | +2,500 | $7.80 | $20K | 4,004 |
| 2021-06-14 | GRIFFIN MICHELLE RENEE Director | Sale | −2,500 | $38.56 | $96K | 1,504 |
| 2021-06-14 | GRIFFIN MICHELLE RENEE Director | Option exercise · Stock Option (Right to Buy) | −2,500 | 73,500 | ||
| 2021-06-14 | ADAMS R MARK Chief Operating Officer | Sale | −8,914 | $38.77 | $346K | 58,104 |
Page 45 of 120 · 2,386 trades